Brown Lisle Cummings Inc. Purchases 2,787 Shares of Danaher Corporation $DHR

Brown Lisle Cummings Inc. increased its holdings in Danaher Corporation (NYSE:DHR) by 219.1% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 4,059 shares of the conglomerate’s stock after buying an additional 2,787 shares during the period. Brown Lisle Cummings Inc.’s holdings in Danaher were worth $899,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of DHR. BlackRock Inc. acquired a new stake in Danaher during the 2nd quarter valued at approximately $10,492,520,000. Wellington Management Group LLP boosted its holdings in shares of Danaher by 10.4% in the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after acquiring an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC acquired a new stake in shares of Danaher in the second quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new stake in shares of Danaher in the second quarter worth $1,287,949,000. Finally, Bank of America Corp DE acquired a new stake in shares of Danaher in the second quarter worth $993,846,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on DHR shares. Stifel Nicolaus reduced their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Guggenheim boosted their target price on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Finally, Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $235.41.

Danaher Stock Down 1.1%

Shares of DHR stock opened at $228.87 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $160.89 billion, a P/E ratio of 40.65, a P/E/G ratio of 2.88 and a beta of 0.76. The stock has a 50 day moving average of $214.04 and a 200 day moving average of $195.97. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 EPS. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s payout ratio is 28.42%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.